Header Logo

Connection

DAVID POPLACK to Drug Evaluation

Back to Details
This is a "connection" page, showing publications DAVID POPLACK has written about Drug Evaluation.
DAVID POPLACK
Connection Strength
0.293
Drug Evaluation
  1. Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule. Cancer Res. 1992 Feb 01; 52(3):521-4.
    View in: PubMed
    Score: 0.025
  2. A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia. Cancer Chemother Pharmacol. 1992; 30(2):155-7.
    View in: PubMed
    Score: 0.025
  3. Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study. Cancer Res. 1991 Nov 15; 51(22):6079-83.
    View in: PubMed
    Score: 0.024
  4. Current pharmacological treatment approaches to central nervous system leukaemia. Drugs. 1991 May; 41(5):702-16.
    View in: PubMed
    Score: 0.023
  5. Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day schedule. Cancer Res. 1990 Aug 01; 50(15):4464-7.
    View in: PubMed
    Score: 0.022
  6. Phase II trial of sequential methotrexate and 5-fluorouracil with leucovorin in children with sarcomas. Invest New Drugs. 1990 May; 8(2):181-2.
    View in: PubMed
    Score: 0.022
  7. A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors. Cancer Chemother Pharmacol. 1990; 26(5):343-4.
    View in: PubMed
    Score: 0.021
  8. Phase I trial and pharmacokinetic evaluation of fazarabine in children. Cancer Res. 1989 Sep 15; 49(18):5213-6.
    View in: PubMed
    Score: 0.021
  9. A pediatric phase I and pharmacokinetic study of spirohydantoin mustard. Cancer Res. 1988 Apr 15; 48(8):2292-5.
    View in: PubMed
    Score: 0.019
  10. Very high dose cyclophosphamide with imidazole carboximide and vincristine sulfate in the treatment of stage IV neuroblastoma. Am J Clin Oncol. 1985 Jun; 8(3):210-4.
    View in: PubMed
    Score: 0.016
  11. Clinical pharmacology of 9-beta-D-arabinofuranosyladenine in combination with 2'-deoxycoformycin. Cancer Res. 1982 Sep; 42(9):3884-6.
    View in: PubMed
    Score: 0.013
  12. Levels of 2'-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia. Cancer Res. 1981 Nov; 41(11 Pt 1):4508-11.
    View in: PubMed
    Score: 0.012
  13. Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia. Cancer Res. 1981 Sep; 41(9 Pt 1):3343-6.
    View in: PubMed
    Score: 0.012
  14. Pharmacokinetics of ICRF-187 in the cerebrospinal fluid of subhuman primates. Cancer Treat Rep. 1980 Apr-May; 64(4-5):734-6.
    View in: PubMed
    Score: 0.011
  15. Serum CD25 levels during interleukin-2 therapy: dose dependence and correlations with clinical toxicity and lymphocyte surface sCD25 expression. J Immunother (1991). 1992 Feb; 11(2):111-8.
    View in: PubMed
    Score: 0.006
  16. Phase I/pharmacokinetic reevaluation of thioTEPA. Cancer Res. 1991 Jun 15; 51(12):3171-6.
    View in: PubMed
    Score: 0.006
  17. Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection. J Pediatr. 1990 Dec; 117(6):980-5.
    View in: PubMed
    Score: 0.006
  18. Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients. Cancer Res. 1990 Nov 15; 50(22):7226-31.
    View in: PubMed
    Score: 0.006
  19. Phase II study of 5-azacytidine in sarcomas of bone. Am J Clin Oncol. 1982 Aug; 5(4):411-5.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.